showed a trendp = 0.055
Conversely, PLHIV with prior zidovudine-use (prior AZT-use, n = 46/184; 25%) showed a trend towards lower copies of mtDNA pl (AZT-use: 7.8 copies/plt [IQR: 6.0, 9.4] vs never-AZT: 8.6 copies/plt [IQR: 6.9, 10.8], p = 0.055).
Conversely, PLHIV with prior zidovudine-use (prior AZT-use, n = 46/184; 25%) showed a trend towards lower copies of mtDNA pl (AZT-use: 7.8 copies/plt [IQR: 6.0, 9.4] vs never-AZT: 8.6 copies/plt [IQR: 6.9, 10.8], p = 0.055).
5 C) and a positive trend was observed with fibrinogen binding (Fig. 5 D).